November 2024 Publications

Bioinformatics Analysis and Immunogenicity Assessment of the Novel Multi-Stage DNA Vaccine W541 Against Mycobacterium Tuberculosis. Yang Y, Xue Y, Wang X, Wang L, Wang J, Zhang J, Liu Y, Liang Y, Wu X. Immun Inflamm Dis. 2024 Nov;12(11):e70074. doi: 10.1002/iid3.70074.  Multilevel Proteomics Reveals Epigenetic Signatures in BCG-Mediated Macrophage Activation. Schaefer Z, Iradukunda J, Lumngwena EN,…

Read More

October 2024 Publications

Implications of subclinical tuberculosis for vaccine trial design and global effect Churchyard GJ, Houben RMGJ, Fielding K, Fiore-Gartland AL, Esmail H, Grant AD, Rangaka MX, Behr M, Garcia-Basteiro AL, Wong EB, Hatherill M, Mave V, Dagnew AF, Schmidt AC, Hanekom WA, Cobelens F, White RG. Lancet Microbe. 2024 Oct;5(10):100895. doi: 10.1016/S2666-5247(24)00127-7. Epub 2024 Jul 1. …

Read More

September 2024 Publications

Immunoproteomic discovery of Mycobacterium bovis antigens, including the surface lipoprotein Mpt83 as a T cell antigen useful for vaccine development. Karunakaran KP, Yu H, Jiang X, Chan QWT, Sigola L, Millis LA, Chen J, Tang P, Foster LJ, Brunham RC. Vaccine. 2024 Sep 2;42(24):126266. doi: 10.1016/j.vaccine.2024.126266. Epub ahead of print.   Antibodies as key mediators…

Read More

July 2024 Publications

Implications of subclinical tuberculosis for vaccine trial design and global effect. Churchyard GJ, Houben RMGJ, Fielding K, Fiore-Gartland AL, Esmail H, Grant AD, Rangaka MX, Behr M, Garcia-Basteiro AL, Wong EB, Hatherill M, Mave V, Dagnew AF, Schmidt AC, Hanekom WA, Cobelens F, White RG. Lancet Microbe. 2024 Jul 1. doi: 10.1016/S2666-5247(24)00127-7. Epub ahead of…

Read More

June 2024 Publications

Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial. Dos Santos PCP, Messina NL, de Oliveira RD, da Silva PV, Puga MAM, Dalcolmo M, Dos Santos G, de Lacerda MVG, Jardim BA, de Almeida E Val FF, Curtis N, Andrews JR, Croda J. Lancet Infect Dis. 2024…

Read More